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The crystal structure of PA1994 from Pseudomonas aeruginosa, a member of the
Pfam PF06475 family classified as a domain of unknown function (DUF1089),
reveals a novel fold comprising a 15-stranded -sheet wrapped around a single
-helix that assembles into a tight dimeric arrangement. The remote structural
similarity to lipoprotein localization factors, in addition to the presence of an
acidic pocket that is conserved in DUF1089 homologs, phospholipid-binding
and sugar-binding proteins, indicate a role for PA1994 and the DUF1089 family
in glycolipid metabolism. Genome-context analysis lends further support to the
involvement of this family of proteins in glycolipid metabolism and indicates
possible activation of DUF1089 homologs under conditions of bacterial cell-wall
stress or host–pathogen interactions.
1. Introduction
In an effort to extend the structural coverage of proteins for which
the biological function is unknown and cannot be deduced by
homology (i.e. domains of unknown function; DUFs), targets were
selected from Pfam protein family PF06745 (DUF1089). DUF1089
homologs are present in pathogenic actinobacteria, burkholderia,
firmicutes and lactobacilli. Here, we report the crystal structure of
PA1994, the first structural representative of this family, which was
determined using the semi-automated high-throughput pipeline of
the Joint Center for Structural Genomics (JCSG; http://www.jcsg.org;
Lesley et al., 2002) as part of the NIGMS Protein Structure Initiative
(PSI; http://www.nigms.nih.gov/Initiatives/PSI/). The PA1994 gene of
Pseudomonas aeruginosa, an opportunistic human pathogen (Gomez
& Prince, 2007), encodes a protein with a molecular weight of
21.6 kDa (residues 1–187) and a calculated isoelectric point of 4.9.
We show that global and local structural and chemical similarities
to lipid-binding proteins suggest the involvement of PA1994 with the
bacterial membrane, while genome-context analysis supports a role
for the DUF1089 family in glycolipid metabolism that is likely to
be triggered under conditions of osmotic stress or host–pathogen
interactions. These structural insights should help to guide future
functional studies.
2. Materials and methods
2.1. Protein production and crystallization
Clones were generated using the Polymerase Incomplete Primer
Extension (PIPE) cloning method (Klock et al., 2008). The gene
encoding PA1994 (GenBank NP_250684; gi:15597190; Swiss-Prot
Q912B5) was amplified by polymerase chain reaction (PCR) from
P. aeruginosa PA01-LAC genomic DNA using PfuTurbo DNA
polymerase (Stratagene) and I-PIPE (Insert) primers (forward
primer, 50-ctgtacttccagggcATGAGTCGCGACCGTCTGTACACCT-
GGG-30; reverse primer, 50-aattaagtcgcgttaGAGACGCTGGAAG-
AGACCCGGGTAATCG-30; target sequence in upper case) that
included sequences for the predicted 50 and 30 ends. The expression
vector pSpeedET, which encodes an amino-terminal tobacco etch
virus (TEV) protease-cleavable expression and purification tag
(MGSDKIHHHHHHENLYFQ/G), was PCR-amplified with V-PIPE
(Vector) primers (forward primer, 50-taacgcgacttaattaactcgtttaaacgg-
tctccagc-30; reverse primer, 50-gccctggaagtacaggttttcgtgatgatgatgatg-
atg-30). V-PIPE and I-PIPE PCR products were mixed to anneal the
amplified DNA fragments. Escherichia coli GeneHogs (Invitrogen)
competent cells were transformed with the V-PIPE/I-PIPE mixture
and dispensed onto selective LB–agar plates. The cloning junctions
were confirmed by DNA sequencing. Expression was performed in
selenomethionine-containing medium with suppression of normal
methionine synthesis. At the end of fermentation, lysozyme was
added to the culture to a final concentration of 250 mg ml1 and the
cells were harvested and frozen. After one freeze–thaw cycle, the
cells were sonicated in lysis buffer [50 mM HEPES pH 8.0, 50 mM
NaCl, 10 mM imidazole, 1 mM tris(2-carboxyethyl)phosphine–HCl
(TCEP)] and the lysate was clarified by centrifugation at 32 500g for
30 min. The soluble fraction was passed over nickel-chelating resin
(GE Healthcare) pre-equilibrated with lysis buffer, the resin was
washed with wash buffer [50 mM HEPES pH 8.0, 300 mM NaCl,
40 mM imidazole, 10%(v/v) glycerol, 1 mM TCEP] and the protein
was eluted with elution buffer [20 mM HEPES pH 8.0, 300 mM
imidazole, 10%(v/v) glycerol, 1 mM TCEP]. The eluate was buffer-
exchanged with HEPES crystallization buffer (20 mM HEPES pH
8.0, 200 mM NaCl, 40 mM imidazole, 1 mM TCEP) using a PD-10
column (GE Healthcare) and incubated with 1 mg TEV protease per
15 mg eluted protein. The protease-treated eluate was passed over
nickel-chelating resin (GE Healthcare) pre-equilibrated with HEPES
crystallization buffer and the resin was washed with the same buffer.
The flowthrough and wash fractions were combined and concentrated
to 11.2 mg ml1 by centrifugal ultrafiltration (Millipore) for crystal-
lization trials. PA1994 was crystallized using the nanodroplet vapor-
diffusion method (Santarsiero et al., 2002) with standard JCSG
crystallization protocols (Lesley et al., 2002). Sitting drops composed
of 200 nl protein solution mixed with 200 nl crystallization solution
were equilibrated against a 50 ml reservoir at 277 K for 40 d prior
to harvesting. Initial screening for diffraction was carried out
using the Stanford Automated Mounting system (SAM; http://
smb.slac.stanford.edu/facilities/hardware/SAM/UserInfo; Cohen et
al., 2002) at the Stanford Synchrotron Radiation Lightsource (SSRL;
Menlo Park, California, USA). The crystallization reagent that
produced the PA1994 crystal used for the structure solution con-
tained 5%(v/v) 2-methyl-2,4-pentanediol (MPD; racemic mixture),
10%(w/v) PEG 6000 and 0.1M HEPES pH 7.5. Ethylene glycol was
added to the crystal as a cryoprotectant to a final concentration of
15%(v/v). A rod-shaped crystal with approximate dimensions of
200  20  20 mm was mounted in a nylon loop. The diffraction data
were indexed in the monoclinic space group C2 (Table 1). The
molecular weight and oligomeric state of PA1994 were determined
using a 0.8  30 cm Shodex Protein KW-803 column (Thomson
Instruments) pre-calibrated with gel-filtration standards (Bio-Rad).
2.2. Data collection, structure solution and refinement
Multiple-wavelength anomalous diffraction (MAD) data were
collected at SSRL on beamline BL11-1 at wavelengths corresponding
to the inflection (1), peak (2) and high-energy remote (3) of a
selenium MAD experiment. The data sets were collected at 100 K
with an ADSC Q315 CCD detector using the Blu-Ice data-collection
environment (McPhillips et al., 2002). The MAD data were integrated
and reduced using XDS and then scaled with the program XSCALE
(Kabsch, 1993). Phasing was performed with SHELX (Sheldrick,
2008) and AutoSHARP (Bricogne et al., 2003), which resulted in a
mean figure of merit of 0.15 with four selenium positions. Two were
high occupancy, corresponding to the main selenium positions at
residues A143 and B143, whereas the others were low occupancy
(20% relative to the primary site), corresponding to an alternate
conformation of residue 143 in each monomer (<4.7 A˚ from the
primary site). It should be noted that the presence of only one
ordered SeMet site (two conformations) per 188 residues in the
protein chain sufficed for successful phasing and model building.
Automated model building was performed with ARP/wARP (Cohen
et al., 2004) and model completion and refinement were performed
with Coot (Emsley & Cowtan, 2004) and REFMAC 5.2 (Winn et al.,
2003). Refinement included phase restraints from AutoSHARP and
TLS refinement with two TLS groups per chain as suggested by the
TLSMD server (Painter & Merritt, 2006). Data reduction and
refinement statistics are summarized in Table 1.
2.3. Validation and deposition
Analysis of the stereochemical quality of the model was accom-
plished using AutoDepInputTool (Yang et al., 2004), MolProbity
(Davis et al., 2004), SFCHECK 4.0 (Collaborative Computational
Project, Number 4, 1994) and WHATIF 5.0 (Vriend, 1990). Protein
quaternary-structure analysis was performed using the PISA server
(Krissinel & Henrick, 2007). Fig. 1(c) was adapted from an analysis
using PDBsum (Laskowski et al., 2005) and all other figures were
prepared with PyMOL (DeLano Scientific). Atomic coordinates and
experimental structure factors for PA1994 at 1.80 A˚ resolution have
been deposited in the PDB under accession code 2h1t.
structural communications
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Table 1
Summary of crystal parameters, data collection and refinement statistics for PA1994
(PDB code 2h1t).
Values in parentheses are for the highest resolution shell.
1 MADSe 2 MADSe 3 MADSe
Space group C2
Unit-cell parameters (A˚, ) a = 130.03, b = 41.90, c = 78.65,  = 91.2
Data collection
Wavelength (A˚) 0.9793 0.9789 0.9116
Resolution range (A˚) 28.3–1.80
(1.85–1.80)
28.3–1.91
(1.96–1.91)
28.3–1.80
(1.85–1.80)
No. of observations 136388 121791 146173
No. of unique reflections 38719 33103 39473
Completeness (%) 98.0 (83.9) 99.6 (97.2) 99.7 (98.3)
Mean I/(I) 9.9 (1.9) 10.6 (3.4) 10.3 (2.6)
Rmerge on I† (%) 9.9 (51.4) 10.5 (35.1) 9.9 (51.7)
Model and refinement statistics
Resolution range (A˚) 28.3–1.80
No. of reflections (total) 35699‡
No. of reflections (test) 1772
Completeness (%) 90.2
Data set used in refinement 1 MADSe
Cutoff criterion |F | > 0
Rcryst§ 0.170
Rfree} 0.213
Stereochemical parameters
Restraints (r.m.s.d. observed)
Bond angles () 1.58
Bond lengths (A˚) 0.015
Average isotropic B value (A˚2) 20.5††
ESU‡‡ based on Rfree (A˚) 0.13
Protein residues/atoms 370/3051
Waters/other solvent molecules 367/11
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Owing to ice rings, a total of
3016 reflections were omitted from the resolution ranges 1.91–1.93, 2.02–2.04 and
2.23–2.27 A˚. Typically, a few reflections were also excluded owing to negative intensities
and rounding errors in the resolution limits and unit-cell parameters. § Rcryst =P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fcalc and Fobs are the calculated and observed
structure-factor amplitudes, respectively } Rfree is the same as Rcryst but for 5.0% of the
total reflections chosen at random and omitted from refinement. †† This represents the
total B including both the TLS and residual B components. ‡‡ Estimated overall
coordinate error (Collaborative Computational Project, Number 4, 1994; Cruickshank,
1999).
3. Results and discussion
3.1. Overall structure
The crystal structure of PA1994 (Fig. 1a) was determined to 1.80 A˚
resolution using the multiple-wavelength anomalous dispersion
(MAD) method. Refinement statistics are summarized in Table 1.
The final model includes 370 residues (residues 2–187 of chain A and
residues 4–187 of chain B), nine ethylene glycol molecules, two MPD
molecules and 367 water molecules in the asymmetric unit. No
electron density was observed for the N-terminal glycine (0)
structural communications
Acta Cryst. (2010). F66, 1211–1217 Bakolitsa et al.  PA1994 1213
Figure 1
Crystal structure of PA1994 from P. aeruginosa. (a) Stereo ribbon diagram of the PA1994 monomer color coded from the N-terminus (blue) to the C-terminus (red). Helices
(H1–H2) and -strands (1–15) are indicated. (b) Ribbon representation of the PA1994 dimer showing domain swapping of the N-terminal -strands. Monomers are
depicted in blue and magenta. (c) Diagram showing the secondary-structure elements of PA1994 superimposed on its primary sequence. The labeling of secondary-structure
elements is in accord with PDBsum (http://www.ebi.ac.uk/pdbsum), where -helices are sequentially labeled (H1, H2, H3 etc.), -strands are labeled (A, B, C etc.) according
to the -sheets to which they are assigned, -turns and -turns are designated by Greek letters (, ) and -hairpins are designated by red loops. For PA1994, the -helix
(H2), 310-helix (H1), -strands in -sheets (A–C), -turns () and -hairpins are indicated.
remaining after cleavage of the expression and purification tag, for
the terminal selenomethionine (residue 1) of chains A and B or for
Ser2 and Arg3 in chain B. The side chains of Arg5 and Glu91 in chain
B were omitted owing to weak electron density. The Matthews
coefficient (VM; Matthews, 1968) was 2.5 A˚
3 Da1 and the estimated
solvent content was 50.1%. A Ramachandran plot produced by
MolProbity (Davis et al., 2004) showed that 99.2% of the residues are
in favored regions. The two outliers, Pro106 in chains A and B, are
actually found in a cis conformation in both chains and have clear
electron density.
SCOP (release 1.75) classifies PA1994 as a single-domain protein
with a novel fold termed a spiral -roll (http://scop.mrc-lmb.
cam.ac.uk/scop/data/scop.b.c.bdb.b.b.b.html), with a 15-stranded -
sheet wrapped around a central helix (Fig. 1). The N-terminal half of
the sheet is formed by strands 3–7 supplemented by a 1-strand
exchange from the other monomer in the asymmetric unit (Fig. 1b)
that hydrogen bonds extensively to the 3 and the shorter 15 strands
(Figs. 1a and 1b). This swapping additionally involves strand 2 and
results in a large buried dimerization interface of 3000 A˚2 per
monomer. A short -strand (8) and 310-helix H1 separate the first
half of the -sheet from the more tightly curved C-terminal region
(strands 10–15). Helix H2 and strand 9 are sandwiched between
the two halves of the -sheet in the center of the molecule.
PA1994 can be viewed as consisting of two subdomains: the first
half of the -sheet (10, 3–8) and helix H1 (residues 1–98) compose
the first domain, which packs against the other subdomain consisting
of the second half of the -sheet (9–15) and helix H2 (residues 99–
187). Both subdomains are present in DUF1089-family members and
a sequence analysis of the family indicates a high degree of conser-
vation in the residues that are implicated in stabilizing both regions of
the molecule. Stacking interactions, both intermolecular (Trp9–
Pro1080) and intramolecular (Trp57–Phe113), show strict or high
conservation. Additionally, conserved stacking interactions are
observed in residue pairs involving the H2 helix and both the
N-terminal (Trp57–Phe113) and the C-terminal (Pro114–Tyr147)
halves of the -sheet, as well as the conserved binding-pocket resi-
dues (Trp9–Pro1080, Trp57–Phe113 and Pro106/Pro108–Phe184; see
below).
A search with FATCAT (Ye & Godzik, 2004) identified that the
highest structural similarity is with outer membrane proteins (SH3-
like barrel fold), NTF2-like proteins (cystatin-like fold) and fatty
acid-binding proteins (lipocalin fold). DALI (Holm & Sander, 1995)
showed significant hits with a number of different folds, including
-galactosidase (immunoglobulin-like -sandwich fold), iron-trans-
port proteins (transmembrane -barrel fold), lipovitellin (lipo-
vitellin–phosvitin complex/-sheet shell regions fold), tail-associated
lysozyme (phage-tail protein fold) and lipoprotein localization factors
(prokaryotic lipoprotein localization factor fold). A search using
secondary-structure matching (SSM; Krissinel & Henrick, 2004)
identified the lipoprotein localization factor LolA (PDB code 1iwl) as
the top hit (Z score 2.5, P score 0.0), although the P score indicates a
statistically insignificant match.
structural communications
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Figure 2
PA1994 exhibits structural similarity to the lipoprotein chaperones LolA and LolB. (a) Stereoview of the structural superposition of PA1994 (PDB code 2h1t, residues 2–187,
blue) and LolA (PDB code 1iwl, residues 1–182, gray). (b) Stereoview of the structural superposition of PA1994 (PDB code 2h1t, residues 2–187, blue) and LolB (PDB code
1iwn, residues 10–186, gray).
Although PA1994 appears to constitute a new fold, we decided to
investigate subfold similarities in an attempt to identify shared
structural features that could provide insight into the origin and
function of PA1994. The highest structural similarity identified by
visual inspection was with lipoprotein localization factors A and B
(LolA and LolB) from E. coli, which are highly conserved bacterial
proteins that are implicated in lipoprotein sorting and membrane
localization (Takeda et al., 2003). Superimposition of PA1994 onto
LolA, with an r.m.s.d. of 3.1 A˚, reveals that these proteins share the
same fold and topology over the 11 -strands and the central helix,
although the sequence identity over 104 aligned residues is not
significant at only 5% (Fig. 2a). Differences within the barrel include
PA1994 strands 9–10, which are absent in both lipoprotein local-
ization factors, strand 8 (absent in LolA) and the orientation of the
central helix in LolB (Figs. 2a and 2b). Outside the barrel, the main
differences involve an additional N-terminal helix in LolA located at
the bottom of the -barrel and the LolA C-terminal 310-helix and
-strand (Figs. 2a and 2b). Both of these C-terminal structural
elements, which are absent in PA1994, are involved in the specific
membrane localization of lipoproteins by LolA (Okuda et al., 2008).
No strand-swapping is observed in either LolA or LolB, although the
N-terminal -strand is present in both cases and overlaps with the
swapped strand from the PA1994 dimer.
3.2. Analysis of a conserved cavity
An analysis of PA1994 using the CastP server (Binkowski et al.,
2003) revealed a deep pocket (15 6 7 A˚) enclosed mainly by helix
H2 and strand 7, with additional contributions made by strands 10–
12 and the loop between strands 14 and 15. This pocket is lined
with conserved hydrophilic residues (Ser107, Thr110, Asn111, Thr112
and Gln145) and contains the hydroxyl group of the invariant Tyr147
in addition to an acidic pocket formed by two invariant aspartates
(Asp101 and Asp103; Fig. 3). The pocket is in a similar location to the
cavity in LolA that has been shown to bind lipids (Watanabe et al.,
2006). However, the binding pocket is hydrophobic in LolA, whereas
the PA1994 pocket is acidic, suggesting a more hydrophilic ligand.
The entrance to the pocket in PA1994 forms a long and narrow
groove (20  7 A˚) composed of strictly or highly conserved hydro-
phobic residues (Ile102, Pro106, Pro108, Phe165, Leu170 and Ile178)
and also involves the dimerization interface (Trp13), suggesting a
hydrophobic component of the ligand and the likely requirement of
dimerization for binding. Analytical size-exclusion chromatography
in combination with static light scattering indicates that PA1994 is a
dimer in solution. Two crystallization-reagent molecules (ethylene
glycol and MPD) line both the groove and the pocket, indicating that
both regions could be implicated in ligand binding (Fig. 3b). Both
LolA and PA1994 contain a cis-proline (Pro89 in LolA and Pro106 in
PA1994) at the N-terminal end of the central helix. Because of the
relatively low energy barrier between trans and cis conformations, cis-
prolines are often involved in function and have been implicated in
both protein stabilization (Truckses et al., 1996) and catalysis (Char-
bonnier et al., 1999), suggesting that this residue might serve a similar
purpose in LolA and PA1994.
A search against a database of nonredundant cognate binding sites
using IsoCleft (Najmanovich et al., 2008), a graph-matching algorithm
that searches for both geometrical and chemical composition simi-
larities, identified shared features between the PA1994 pocket and
the binding sites of proteins implicated in bacterial cell-wall
biosynthesis, with alanine racemase from P. aeruginosa (PDB code
1rcq; 21 atoms in common, Tanimoto similarity score 0.39, Z score
4.26, P value 7.54  103; LeMagueres et al., 2003) and hyaluronate
lyase from Streptococcus pneumoniae (PDB code 1loh; 21 atoms
in common, Tanimoto similarity score 0.38, Z score 4.01, P value
1.03  102; Jedrzejas et al., 2002) as the top hits. Additional simi-
larities include the binding of sugars, with galactose mutarotase (PDB
code 1so0; 25 atoms in common, Tanimoto similarity score 0.38, Z
score 4.08, P value 9.44  103; Thoden et al., 2004) and meso-2,3-
butanediol dehydrogenase (PDB code 1geg; 20 atoms in common,
Tanimoto similarity score 0.36, Z score 3.82, P value 1.32 102;
Otagiri et al., 2001) as the closest matches, in addition to an inorganic
pyrophosphatase (PDB code 1wpm; 25 atoms in common, Tanimoto
similarity score 0.37, Z score 3.89, P value 1.21  102; Fabrichniy et
al., 2004). IsoCleft also identified similarities between the hydro-
phobic groove along the PA1994 pocket entrance and dimerization
interface and the lipid-binding site in Candida rugosa lipase (PDB
code 1lpn; 31 atoms in common, Tanimoto similarity score 0.20, Z
score 3.98, P value 1.08  102; Grochulski, Bouthillier et al., 1994).
Taken together, these structural and chemical similarities support a
role for PA1996 and the DUF1089 family in glycolipid binding. The
extensive dimerization interface observed in the structure, in addition
to the SEC/SLS data, suggest that a dimer is likely to be the bio-
logically relevant oligomeric state of PA1994. The swapped -strands
appear to participate in stabilizing the conserved cavity. Substrate
binding might induce large-scale conformational changes, as is the
case for the lipid-binding proteins that share structural similarities
with PA1994 (Marland et al., 2006; Oguchi et al., 2008; Grochulski, Li
et al., 1994).
3.3. Genome-context analysis
Glycophospholipids, which are implicated in the synthesis of
complex cell-wall structures that enable some pathogens to modulate
the response by the host immune system, have been suggested to bind
to similar-sized acidic pockets as that observed in PA1994 (Marland et
structural communications
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Figure 3
An acidic pocket conserved in the DUF1089 family suggests a ligand-binding site.
The PA1994 monomers, colored white and blue, are shown as a ribbon diagram and
as a surface representation. Invariant residues (Asp101, Asp103 and Tyr147) are
indicated, with the conserved Asn111 located behind the pocket labeled in
parentheses. The ethylene glycol (EDO) and MPD molecules that line the entrance
to the acidic pocket in the crystal are shown in green.
al., 2006). Glycolipids serve as key immunomodulatory molecules in
host–pathogen interactions (Nigou et al., 2008) and lipases have been
known to act as virulence factors (Smoot, 1997). In addition to their
role in pathogenicity, bacterial cell-wall glycolipids are modified in
response to variations in temperature, pH and other environmental
stressors (Mykytczuk et al., 2007), with changes affecting both the
lipid and sugar composition of the membrane (Bengoechea et al.,
2002; Tymczyszyn et al., 2005).
The genome context (http://string.embl.de) of DUF1089-family
members additionally supports a role in glycolipid biosynthesis which
is likely to be induced under conditions of cell-wall stress or host–
pathogen interactions. PA1994 is predicted with a high degree of
confidence to be in functional association with a peptidyl prolyl cis–
trans isomerase (PA1996), an enzyme that functions as a chaperone
and is up-regulated under conditions of cell-wall stress (Muthaiyan et
al., 2008). The prolyl cis–trans isomerase could also assist in the
folding of PA1994, as Pro106 appears to be involved in stabilization of
both the hydrophobic core and the acidic pocket. Similarly, R02764, a
DUF1089 homologue from Sinorhizobium meliloti, is predicted to be
functionally linked to a glyceraldehyde 3-phosphate dehydrogenase
[R02763, normally a cytosolic enzyme involved in energy metabolism
that shows pH-dependent association with bacterial cell walls
(Antikainen et al., 2007), where it becomes involved in host–pathogen
interactions (Schaumburg et al., 2004)], a transketolase (R02762, an
enzyme implicated in lipopolysaccharide metabolism; Eidels &
Osborn, 1971) and a taurine-uptake ABC transporter (RB0965;
taurine is a constituent of the bacterial cell wall that has been
implicated in membrane stabilization and recovery from osmotic
shock; Yancey, 2005). MT3862, a DUF1089 homologue from Myco-
bacterium tuberculosis, is also predicted with high confidence to be in
functional association with two osmoprotectant proteins (MT3863
and MT3864) implicated in glycine betaine-dependent transport. In
addition to its role in maintaining membrane fluidity, glycine betaine
acts as a chemical chaperone (Diamant et al., 2001), stabilizing
proteins under conditions of environmental stress.
Availability of more DUF1089-member sequences and structures
might shed light on the evolutionary history of this intriguing protein
family. The information presented here, in combination with further
biochemical and biophysical studies, should yield valuable insights
into the functional role of PA1994. Models of PA1994 homologs
can be accessed at http://www1.jcsg.org/cgi-bin/models/get_mor.pl?
key=2hltA.
Additional information about PA1994 is available from TOPSAN
(Krishna et al., 2010) http://www.topsan.org/explore?PDBid=2h1t.
4. Conclusions
The first structural representative of the DUF1089 family reveals a
novel fold. Remote global and local similarities to lipid-binding and
glycan-binding proteins along with genome-context analysis support
a role for PA1994 in glycolipid metabolism that is likely to be induced
under conditions of cell-wall stress or host–pathogen interactions.
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